Precision Optics Schedules Third Quarter of Fiscal Year 2025 Conference Call for May 15, 2025
Precision Optics Corporation (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, has scheduled a conference call to discuss its third quarter fiscal year 2025 financial results on Thursday, May 15, 2025, at 5:00 p.m. ET.
The company will release its financial results and file its 10-Q after market close on the same day. Interested parties can join the call by dialing (844) 735-3662 or (412) 317-5705, or access the live webcast at the provided link. A replay will be available for seven days.
Precision Optics Corporation (NASDAQ: POCI), un'azienda leader nella progettazione e produzione di strumenti ottici avanzati per i settori medico e difesa/aerospaziale, ha programmato una conference call per discutere i risultati finanziari del terzo trimestre dell'anno fiscale 2025 il giovedì 15 maggio 2025, alle 17:00 ET.
La società pubblicherà i risultati finanziari e presenterà il modulo 10-Q dopo la chiusura del mercato nello stesso giorno. Gli interessati possono partecipare alla chiamata componendo il numero (844) 735-3662 o (412) 317-5705, oppure seguire la diretta webcast tramite il link fornito. La registrazione sarà disponibile per sette giorni.
Precision Optics Corporation (NASDAQ: POCI), un destacado diseñador y fabricante de instrumentos ópticos avanzados para las industrias médica y de defensa/aeroespacial, ha programado una conferencia telefónica para discutir los resultados financieros del tercer trimestre del año fiscal 2025 el jueves 15 de mayo de 2025, a las 5:00 p.m. ET.
La empresa publicará sus resultados financieros y presentará el formulario 10-Q después del cierre del mercado el mismo día. Los interesados pueden unirse a la llamada marcando (844) 735-3662 o (412) 317-5705, o acceder a la transmisión en vivo a través del enlace proporcionado. La repetición estará disponible durante siete días.
Precision Optics Corporation (NASDAQ: POCI)는 의료 및 국방/항공우주 산업을 위한 첨단 광학 기기 설계 및 제조 분야의 선도 기업으로, 2025 회계연도 3분기 재무 결과에 대해 논의하기 위한 컨퍼런스 콜을 2025년 5월 15일 목요일 오후 5시(동부시간)에 예정하고 있습니다.
회사는 같은 날 장 마감 후 재무 결과를 발표하고 10-Q 보고서를 제출할 예정입니다. 관심 있는 분들은 (844) 735-3662 또는 (412) 317-5705로 전화하시거나 제공된 링크를 통해 생중계 웹캐스트에 접속할 수 있습니다. 녹화 방송은 7일 동안 제공됩니다.
Precision Optics Corporation (NASDAQ : POCI), un concepteur et fabricant de premier plan d'instruments optiques avancés pour les industries médicale et défense/aérospatiale, a programmé une conférence téléphonique pour discuter des résultats financiers du troisième trimestre de l'exercice 2025 le jeudi 15 mai 2025 à 17h00 ET.
L'entreprise publiera ses résultats financiers et déposera son formulaire 10-Q après la clôture des marchés le même jour. Les personnes intéressées peuvent rejoindre l'appel en composant le (844) 735-3662 ou le (412) 317-5705, ou accéder au webcast en direct via le lien fourni. Un replay sera disponible pendant sept jours.
Precision Optics Corporation (NASDAQ: POCI), ein führender Entwickler und Hersteller fortschrittlicher optischer Instrumente für die Medizin- und Verteidigungs-/Luft- und Raumfahrtindustrie, hat eine Telefonkonferenz zur Besprechung der Finanzergebnisse für das dritte Quartal des Geschäftsjahres 2025 für Donnerstag, den 15. Mai 2025, um 17:00 Uhr ET angesetzt.
Das Unternehmen wird seine Finanzergebnisse am selben Tag nach Börsenschluss veröffentlichen und den 10-Q-Bericht einreichen. Interessierte können an dem Anruf teilnehmen, indem sie (844) 735-3662 oder (412) 317-5705 wählen oder den Live-Webcast über den bereitgestellten Link verfolgen. Eine Aufzeichnung ist sieben Tage lang verfügbar.
- None.
- None.
GARDNER, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company’s third quarter fiscal year 2025 financial results on Thursday, May 15, 2025, at 5:00 p.m. ET.
The Company intends to release its financial results and to file its 10-Q after the close of the market on Thursday, May 15, 2025, followed by the conference call.
Conference Call Details
Date and Time: Thursday, May 15, 2025, at 5:00 p.m. ET.
Call-in Information: Interested parties can access the conference call by dialing (844) 735-3662 or
(412) 317-5705.
Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available at https://app.webinar.net/XMqWYwq1mQa.
Replay: A teleconference replay of the call will be available for seven days, at (877) 344-7529 or (412) 317-0088, replay access code 9425811. A webcast replay will be available at https://app.webinar.net/XMqWYwq1mQa.
About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.
About Forward-Looking Statements
This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the demand for the Company's products, global supply chains and economic activity in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.
Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800
Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com
